World Peptide Cancer Therapeutics Marketplace Reviewed in Topical PNS Pharma Report Published at MarketPublishers.com
01 Sep 2014 • by Natalie Aster
LONDON – Peptide-based cancer therapeutics is more successful in diagnosing and treating rare cancer types compared to conventional treatment options; the latter sometimes cannot be used owing to the lack of specificity or due to their complete ineffectiveness. The suitability and potential of peptide-based medicines to prevent and eradicate cancer has been shown in a slew of clinical trials. At present, combination peptide therapies (both conventional and peptide-based cancer therapeutics are used) are gaining in importance owing to their less toxicity and high effectiveness.
Roche, AngioChem, GlaxoSmithKline, Ipsen, Antigen Express, Galena Biopharma, Amgen, Merck & Co, PeptiDream, and Sanofi are the leading players operating in the global peptide tumour therapeutics field.
Topical research report “Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014” prepared by PNS Pharma gives true insights into peptide cancer therapeutics.
The study uncovers essential information on the mechanism of peptide cancer therapeutics, gives an up-close market outlook and cancer peptide clinical pipeline insight. It examines the peptide cancer therapeutics market dynamics, covering growth drivers and major issues to be solved. The research publication presents a detailed clinical pipeline analysis based on phase, indication, country and company, covering 183 peptide cancer drugs in development, 20 marketed peptide cancer drugs, the majority of drugs (75 drugs) in pre-clinical phase, 143 suspended and discontinued peptides drugs for cancer therapy. Furthermore, future growth prospects of the peptide cancer therapeutics market are thoroughly discussed in the report as well.
Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014
Published: August, 2014
Price: US$ 2,000.00
Other In-demand Life Sciences Markets Analyses by PNS Pharma:
- US CNS Disorders Drug Pipeline Insight 2014
- US Orphan Drug Clinical Pipeline Insight 2014
- Human Papillomavirus Infections Vaccine Pipeline Analysis
- Cancer Cytokines Therapy Pipeline Analysis
- Schizophrenia Drug Market & Pipeline Insight
More topical market research reports by the publisher can be found at PNS Pharma page.